NPI: 1821418096 · CEDAR RAPIDS, IA 52404 · Addiction (Substance Use Disorder) Counselor · NPI assigned 04/25/2014
Authorized official FARLEY, BRIAN controls 20+ related entities in our dataset. Read more
| Authorized Official | FARLEY, BRIAN (VP & SECRETARY) |
| Parent Organization | ACADIA HEALTHCARE COMPANY, INC. |
| NPI Enumeration Date | 04/25/2014 |
Other providers sharing the same authorized official: FARLEY, BRIAN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,382 | $107K |
| 2019 | 134,581 | $1.33M |
| 2020 | 239,161 | $1.59M |
| 2021 | 189,007 | $1.68M |
| 2022 | 68,856 | $1.86M |
| 2023 | 33,054 | $1.71M |
| 2024 | 48,121 | $1.42M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 25,759 | 7,281 | $4.20M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 222,439 | 12,725 | $2.49M |
| S0109 | Methadone, oral, 5 mg | 397,500 | 13,141 | $1.67M |
| 90832 | Psychotherapy, 30 minutes with patient | 16,561 | 6,869 | $497K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) | 1,717 | 1,040 | $224K |
| 90834 | Psychotherapy, 45 minutes with patient | 3,226 | 2,069 | $155K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 5,050 | 2,267 | $128K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 3,831 | 2,035 | $106K |
| 80305 | 6,128 | 5,075 | $62K | |
| J0571 | Buprenorphine, oral, 1 mg | 5,046 | 144 | $40K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code | 767 | 593 | $36K |
| 90837 | Psychotherapy, 53 minutes with patient | 623 | 392 | $31K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 935 | 791 | $27K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 683 | 513 | $19K |
| T1016 | Case management, each 15 minutes | 457 | 229 | $10K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 84 | 65 | $2K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based assessment, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, physical activity and/or nutrition needs and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code | 17 | 13 | $860.95 |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 16,670 | 1,182 | $376.75 |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 16,669 | 1,182 | $50.98 |